Lupin

Lupin appoints Shweta Munjal as Vice President and Head of Corporate Communications

Lupin appoints Shweta Munjal as Vice President and Head of Corporate Communications

Drug major Lupin has appointed Shweta Munjal as Vice President & Head Of Corporate Communications. Prior to joining Lupin she worked ...Read More

Lupin Q2 net profit at Rs 211 cr

Lupin Q2 net profit at Rs 211 cr

The company had posted a net loss of Rs 127.07 crore for the corresponding period of the previous fiscal, Lupin said in a late night regu...Read More

Lupin Q1 net catches Covid, drops 60%

Lupin Q1 net catches Covid, drops 60%

It had posted a profit of Rs 265 crore in Q1 FY20 and Rs 390 crore in Q4 FY20. The revenue in Q1 FY21 fell by 9 per cent year-on-year to ...Read More

Lupin's Mandideep Unit II facility receives EIR from USFDA

Lupin's Mandideep Unit II facility receives EIR from USFDA

Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandid...Read More

Lupin contributes Rs 21 crore towards COVID-19 relief efforts

Lupin contributes Rs 21 crore towards COVID-19 relief efforts

Pharma major Lupin Ltd on Saturday announced a contribution of Rs 21 crore for relief efforts directed towards mitigating the COVID-19 cr...Read More

Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs

Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs

Pharma Major Lupin Limited (Lupin) announced the appointment of Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs....Read More

Lupin launches generic cancer drug in US

Lupin launches generic cancer drug in US

The company's alliance partner Natco had received an approval from the United States Food and Drug Administration (USFDA) earlier for the...Read More

Lupin receives EU GMP certificate for Mammalian facility in Pune

Lupin receives EU GMP certificate for Mammalian facility in Pune

New Delhi: Drug major Lupin Wednesday said the company has received European good manufacturing practice (EU GMP) certificate for its Mam...Read More

Lupin, YL Biologics receive nod to market rheumatoid arthritis drug in Japan

Lupin, YL Biologics receive nod to market rheumatoid arthritis drug in Japan

New Delhi: Drug major Lupin Ltd Tuesday said its Japanese subsidiary and YL Biologics have received an approval to manufacture and sell t...Read More

Sensex falls 218 pts, Nifty below 11k as WPI inflation races to 4-yr high

Sensex falls 218 pts, Nifty below 11k as WPI inflation races to 4-yr high

Mumbai: The benchmark BSE Sensex dropped by around 218 points or 0.60 per cent due to sell-off in banking, pharma, and metal stocks as in...Read More

Lupin founder-  Chairman Desh Bandhu Gupta passes away

Lupin founder- Chairman Desh Bandhu Gupta passes away

New Delhi : Founder and Chairman of pharma major Lupin, Desh Bandhu Gupta passed away on Monday morning in Mumbai. Gupta (79), founded Lu...Read More

Lupin founder and Chairman Desh Bandhu Gupta passes away

Lupin founder and Chairman Desh Bandhu Gupta passes away

New Delhi: Founder and Chairman of pharma major Lupin, Desh Bandhu Gupta passed away this morning in Mumbai. Gupta (79), founded Lupin in...Read More

High-flying stocks catch breath, Sensex, Nifty off record

High-flying stocks catch breath, Sensex, Nifty off record

Mumbai: Stocks took a breather today after three days of a dizzying rally as both the Sensex and the Nifty came down from life highs owin...Read More

placeholder

Equities surge on positive global cues

Mumbai : Positive global cues, coupled with healthy third quarter (Q3) results pushed the Indian equities markets higher on Wednesday. Be...Read More

BSE Sensex off to flying start in Muhurat trading; climbs 154 pts

BSE Sensex off to flying start in Muhurat trading; climbs 154 pts

Mumbai : Market benchmark BSE Sensex rose by over 154 points to trade above the 28,000-mark on sustained buying by participants in the op...Read More

Sensex, Nifty end in red; Cipla top gainer

Sensex, Nifty end in red; Cipla top gainer

New Delhi: The market on Tuesday ended in negative terrain with the Sensex trading down 111.30 points or 0.4 percent at 28523.20.

placeholder

Good show by emerging market companies : Boston Consulting Group

Mumbai  : Despite a slowdown in the global economy, the CAGR of emerging market companies stood at 13 per cent, comparaed to those in mat...Read More

placeholder

Indian pharma cos ink licensing pact with UN-backed MPP

New Delhi : Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among seven drug makers which hav...Read More

placeholder

Lupin shares surge 6%; mcap zooms Rs 4,440 crore          

Mumbai : Shares of pharma firm Lupin soared over 6 per cent today after the company received Establishment Inspection Report (EIR) from t...Read More

Sensex surges 232 points

Sensex surges 232 points

Mumbai  : RBI’s decision to remain accommodative propelled market to an over 7-month high as the Sensex wrested back control of the cruci...Read More

Free Press Journal

www.freepressjournal.in